Efecto a largo plazo de los inhibidores de la enzima conversora de la angiotensina en niños con proteinuria

Broyer, 1983, Protéinurie et syndrome néphrotique, 259

Remuzzi, 1990, International Society of Nephrology. Is glomerulosclerosis a consequence of alterd glomerular permeability to macromolecules?, Kidney Int, 38, 384, 10.1038/ki.1990.217

Bertani, 1986, Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy, Kidney Int, 30, 488, 10.1038/ki.1986.212

Rennke, 1989, Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis, Am J Kidney Dis, 13, 443, 10.1016/S0272-6386(89)80001-0

Benner, 1982, Dietary protein intake and the progressive nature of kidney disease: the role of hemodinamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsinc renal disease, N Engl J Med, 307, 652, 10.1056/NEJM198209093071104

Diamond, 1988, Focal and segmental glomerulosclerosis: analogies to atherosclerosis, Kidney Int, 33, 917, 10.1038/ki.1988.87

Klahr, 1986, The influence of anticoagulation on the progression of experimental renal disease, 45

Ibels, 1981, Calcification in end-stage kidneys, Am J Med, 71, 33, 10.1016/0002-9343(81)90255-2

Yoshida, 1989, Gloerular hemodynamic changes vs hypertrophy in experimental glomerular sclerosis, Kidney Int, 35, 654, 10.1038/ki.1989.35

1997, Nefrología, 6, 467

1996, Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria, Diabetologia, 39, 587, 10.1007/BF00403306

1995, The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria, Am J Med, 99, 497, 10.1016/S0002-9343(99)80226-5

Hebert, 1994, Remision of nephrotic range proteinuria in type I diabetes. Collaborative Study Group, Kidney Int, 46, 1688, 10.1038/ki.1994.469

Viberti, 1994, Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria captopril Study Group, JAMA, 271, 275, 10.1001/jama.1994.03510280037029

Kurkus, 1990, Reduction of albuminuria after angiotensin converting enzyme inhibition in various renal disorders, Scand J Urol Nephrol, 24, 63, 10.3109/00365599009180362

Fabbri, 1990, Antiproteinuric effect of angiotensin-converting- enzyme inhibitors in patients with primary glomerular disease and normal renal function, Nephrol Dial Transplant, 5, 81, 10.1093/ndt/5.suppl_1.81

1981, The primary syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone, J Pediatr, 98, 561, 10.1016/S0022-3476(81)80760-3

Tina, 1990, Hematuria and proteinuria, 133

Andre, 1980, Tensión arterielle chez l’enfant et l’adollescent, Arch Fr Pediatr, 37, 477

Camacho, 1985, Nefropatía de Schönlein-Henoch en la infancia. Estudio clínico e histológico de 31 casos, An Esp Pediatr, 22, 12

Trachtman, 1988, Effect of angiotensin-converting enzime inhibitor therapy on proteinuriain children with renal disease, J Pediatr, 112, 295, 10.1016/S0022-3476(88)80073-8

Milliner, 1991, Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome, Pediatr Nephrol, 5, 587, 10.1007/BF00856646

Guez, 1998, Adequate clinical control of congenital nephrotic syndrome by enalapril, Pediatr Nephrol, 12, 130, 10.1007/s004670050420

Pomeranz, 1995, Successful treatment of Finnish congenital nephrotic syndrome with captopril and indometacin, J Pediatr, 126, 140, 10.1016/S0022-3476(95)70518-X

Lama, 1997, Angiotensin converting enzyme inhibitors and reflux nephropathy: 2 years follow-up, Pediatr Nephrol, 11, 714, 10.1007/s004670050373

Huissoon, 1991, Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy, Ir J Med Sci, 160, 319, 10.1007/BF02957863

Navis, 1997, panacea for progressive renal disease?, Lancet, 349, 1852, 10.1016/S0140-6736(97)22026-X

1997, Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy, Lancet, 349, 1857, 10.1016/S0140-6736(96)11445-8